OBrien Thomas M purchased $1.2M of BCBP

OBrien Thomas M (CHIEF EXECUTIVE OFFICER) purchased 160,000 shares of BCB BANCORP INC (BCBP) at $7.75 ($1.24M total) on 2026-09-18.

Original reporting
SEC EDGAR · OBrien Thomas M
Published Sep 22, 2026, 6:23 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 22, 2026, 7:36 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$BCBP
Bullish
medium confidence
Mentioned
$BCBP
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$BCBPBullishMed
01

Why it matters

The purchase adds confidence in management's outlook, may attract short-term buyers.

02

Market read

CEO's $1.24M share purchase could influence BCBP's near-term price action.

03

What to watch

Potential upcoming earnings or regulatory changes could affect the stock regardless of insider activity.

Relevance 7/10Novelty 6/10Timing: filed 2026-09-22 after market close

Background

Form 4 filing reveals insider transaction details.

Company-level read

Ticker impact

$BCBPBullishMedium confidence
Context

CEO Thomas O'Brien bought 160,000 shares for $1.24M, increasing his stake to 869,220 shares.

Expected impact

Potential modest price lift as market views purchase favorably.

Evidence & confidence

CEO buying over $1M of stock is material for a mid-cap; investors often react positively to insider buying.

Market effects

None significant beyond BCB Bancorp.

Limited to U.S. banking sector sentiment.

Low

Counterpoint

Insider buying may be routine portfolio rebalancing, not a strong bullish signal.

Key entities

  • Thomas O'Brien

    Chief Executive Officer of BCB Bancorp

  • BCB Bancorp Inc

    U.S. regional bank holding company

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$BCBPMed

BCB Bancorp Inc (BCBP) (Q3 2026) Earnings Call Highlights: Classified Loans Slashed 70%

BCB Bancorp (BCBP) reported Q3 2026 earnings, highlighting a 70% reduction in classified loans. CEO Thomas O'Brien discussed recapturing deferred tax assets, expense run rates, and cannabis loan transactions. Criticized loans decreased from $207 million to $153 million. The Business Express loan portfolio showed improved performance. The bank completed a successful capital raise and expects better results in Q4.

$BCBPMed

BCB Bancorp, Inc. Announces Results for the Third Quarter 2026

BCB BANCORP INC (BCBP) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 C ONTACT : J AWAD C HAUDHRY , EVP, CFO & T REASURER (201) 823-0700 BCB Bancorp, Inc. Announces Results for the Third Quarter 2026; Achieves Substantial Progress Towards Restructured Balance Sheet. • Successfully completed a $98.0 million equity capital raise through

$BCBPMed

Piper Sandler cuts BCB Bancorp stock price target after dilutive offering

Piper Sandler reduced its price target on BCB Bancorp (BCBP) to $9.50 from $11.00, maintaining a Neutral rating. The bank raised $98 million via a dilutive offering, resulting in 41% ownership dilution. Piper Sandler described the capital raise as aggressive but necessary. BCBP reported a loss of $1.11 per share over the last twelve months but expects profitability this year. The stock traded 13% above the deal price post-announcement.